B. Riley Has Pessimistic Outlook of Abacus Life Q3 Earnings

Key Points

• B. Riley has revised down its Q3 2025 earnings per share (EPS) forecast for Abacus Life from $0.20 to $0.16, while the consensus estimate for the company's full-year EPS stands at $0.62.
• Despite a positive earnings report for the last quarter, where Abacus Life exceeded expectations with $0.22 EPS, the company's future outlook has become more cautious.
• Analysts have mixed ratings for Abacus Life, with a total of six analysts recommending a buy rating and a consensus target price of $13.70.

Abacus Life, Inc. (NASDAQ:ABL - Free Report) - Analysts at B. Riley lowered their Q3 2025 earnings per share (EPS) estimates for Abacus Life in a note issued to investors on Wednesday, August 13th. B. Riley analyst R. Binner now expects that the company will earn $0.16 per share for the quarter, down from their previous estimate of $0.20. The consensus estimate for Abacus Life's current full-year earnings is $0.62 per share.

Several other research analysts have also recently commented on ABL. Maxim Group assumed coverage on Abacus Life in a research report on Tuesday, April 29th. They issued a "buy" rating and a $14.00 target price for the company. Piper Sandler dropped their price objective on shares of Abacus Life from $12.00 to $10.00 and set an "overweight" rating for the company in a research note on Wednesday, July 2nd. Finally, Wall Street Zen upgraded shares of Abacus Life from a "hold" rating to a "buy" rating in a research note on Saturday, August 9th. One analyst has rated the stock with a Strong Buy rating and five have issued a Buy rating to the stock. According to MarketBeat, Abacus Life presently has an average rating of "Buy" and a consensus target price of $13.70.

Abacus Life Stock Performance

Shares of ABL traded down $0.03 during mid-day trading on Friday, hitting $6.41. The company's stock had a trading volume of 312,070 shares, compared to its average volume of 602,771. Abacus Life has a one year low of $4.60 and a one year high of $10.95. The company has a debt-to-equity ratio of 0.57, a quick ratio of 0.76 and a current ratio of 0.76. The firm has a market capitalization of $620.81 million, a PE ratio of -106.83 and a beta of 0.01. The stock's 50-day moving average is $5.51 and its two-hundred day moving average is $6.96.

Abacus Life (NASDAQ:ABL - Get Free Report) last posted its quarterly earnings data on Thursday, August 7th. The company reported $0.22 earnings per share for the quarter, beating the consensus estimate of $0.16 by $0.06. Abacus Life had a positive return on equity of 17.65% and a negative net margin of 0.72%.The company had revenue of $56.23 million during the quarter, compared to analysts' expectations of $43.38 million.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently made changes to their positions in the stock. Alyeska Investment Group L.P. lifted its holdings in shares of Abacus Life by 116.5% during the fourth quarter. Alyeska Investment Group L.P. now owns 2,540,790 shares of the company's stock valued at $19,894,000 after acquiring an additional 1,367,210 shares during the period. Goldman Sachs Group Inc. lifted its holdings in shares of Abacus Life by 13.0% during the first quarter. Goldman Sachs Group Inc. now owns 1,928,293 shares of the company's stock valued at $14,443,000 after acquiring an additional 221,712 shares during the period. Royce & Associates LP increased its stake in shares of Abacus Life by 39.6% in the first quarter. Royce & Associates LP now owns 1,824,253 shares of the company's stock valued at $13,664,000 after buying an additional 517,822 shares in the last quarter. Mendon Capital Advisors Corp increased its stake in shares of Abacus Life by 13.9% in the second quarter. Mendon Capital Advisors Corp now owns 1,619,342 shares of the company's stock valued at $8,323,000 after buying an additional 197,171 shares in the last quarter. Finally, Allspring Global Investments Holdings LLC increased its stake in shares of Abacus Life by 6.2% in the second quarter. Allspring Global Investments Holdings LLC now owns 1,475,053 shares of the company's stock valued at $7,818,000 after buying an additional 86,705 shares in the last quarter.

Abacus Life Company Profile

Abacus Life, Inc operates as an alternative asset manager specializing in life insurance products. It purchases life insurance policies from consumers seeking liquidity and manages policies over time via trading, holding, and/or servicing. The company was founded in 2004 and is based in Orlando, Florida.